Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C9FX
|
|||
| Former ID |
DNC001774
|
|||
| Drug Name |
ISIS 330012
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | CRP messenger RNA (CRP mRNA) | Target Info | . | [1] |
| NetPath Pathway | Leptin Signaling Pathway | |||
| Pathway Interaction Database | IL6-mediated signaling events | |||
| WikiPathways | IL-6 signaling pathway | |||
| Human Complement System | ||||
| Complement cascade | ||||
| Folate Metabolism | ||||
| Vitamin B12 Metabolism | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 7,425,545, Modulation of C-reactive protein expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.